Back to top

Analyst Maintains Hold on Edwards with Neutral Risk-Reward and Reiterated $85 Price Target Amid Pending TAVR Catalysts

Canaccord Genuity analyst William Plovanic maintained a Hold rating on Edwards Lifesciences yesterday and set a price target of $85.00. William Plo...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Edwards Lifesciences Corporation (EW)

iShares MSCI Switzerland ETF (EWL)